Status:
COMPLETED
Exercise-based Cardiac Rehabilitation After Thoracoscopic Ablation in Patients With Persisent Atrial Fibrillation
Lead Sponsor:
Samsung Medical Center
Conditions:
Atrial Fibrillation, Persistent
Cardiac Rehabilitation
Eligibility:
All Genders
18-80 years
Brief Summary
Thoracoscopic ablation is a promising treatment of persistent atrial fibrillation. However, the postoperative rehabilitation is very important to prevent early recurrence of atrial arrhythmia. The pur...
Eligibility Criteria
Inclusion
- patients who underwent thoracoscopic ablation due to persisent atrial fibrillation
Exclusion
- below 18 years
- over 80 years old
- malignancy
- pregnancy
Key Trial Info
Start Date :
June 1 2017
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 31 2020
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT04500184
Start Date
June 1 2017
End Date
May 31 2020
Last Update
August 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 135-710